Module 226

General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets:	2
Num genes:	27 (see 1454 additional genes for this module)
Num experiments:	71 (33 induced, 38 repressed)
Parent module:	281
Children modules:	None

Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
protein phosphatase regulator activity
phosphatase regulator activity

Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation	Category	P-value	Hits	Hits(%)	Module hits in category	Arrays in annotation	Arrays
Hematologic cancer and cell line (Stimulated immune*)	Stimulated immune*	4.0e-15	15	39.4	38	53	1945
Hematologic samples and cell lines (Stimulated immune*)	Stimulated immune*	4.0e-15	15	39.4	38	53	1945
Macrophages (Stimulated immune*)	Stimulated immune*	4.0e-15	15	39.4	38	53	1945
Monocytes (Stimulated immune*)	Stimulated immune*	4.0e-15	15	39.4	38	53	1945
Hematologic cancer and cell line (Stimulated immune*)	Stimulated immune*	3.7e-13	13	39.3	33	53	1945
Hematologic samples and cell lines (Stimulated immune*)	Stimulated immune*	3.7e-13	13	39.3	33	53	1945
Macrophages (Stimulated immune*)	Stimulated immune*	3.7e-13	13	39.3	33	53	1945
Monocytes (Stimulated immune*)	Stimulated immune*	3.7e-13	13	39.3	33	53	1945
CNS cancer or cell line (Neuro tumors*)	Neuro tumors*	1.4e-05	9	23.6	38	81	1945
CNS tumor (Neuro tumors*)	Neuro tumors*	1.4e-05	9	23.6	38	81	1945
CNS tissue, cancer or cell line (Neuro tumors*)	Neuro tumors*	2.1e-05	9	23.6	38	85	1945
Cancer and cell line (Neuro tumors*)	Neuro tumors*	2.4e-05	9	23.6	38	86	1945
Cancer (Neuro tumors*)	Neuro tumors*	2.4e-05	9	23.6	38	86	1945

Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation	P-value	Hits	Hits(%)	Module genes	Genes in annotation	Genes
phosphatase regulator activity	4.4e-53	27	100	27	66	4566
protein phosphatase regulator activity	8.2e-50	26	96.2	27	65	4566
enzyme regulator activity	1.0e-33	27	100	27	287	4566
enzyme activator activity	1.4e-18	12	44.4	27	43	4566
calcium-dependent protein serine/threonine phosphatase activity	1.4e-17	10	37.0	27	24	4566
protein phosphatase type 2C activity	1.4e-17	10	37.0	27	24	4566
protein phosphatase type 2A activity	2.2e-16	10	37.0	27	30	4566
protein serine/threonine phosphatase activity	2.2e-16	10	37.0	27	30	4566
protein phosphatase activity	2.1e-12	10	37.0	27	69	4566
phosphoric monoester hydrolase activity	2.4e-11	10	37.0	27	87	4566
phosphoric ester hydrolase activity	4.4e-10	10	37.0	27	116	4566
protein amino acid dephosphorylation	1.0e-09	8	29.6	27	60	4566
manganese ion binding	1.6e-09	6	22.2	27	22	4566
protein tyrosine/serine/threonine phosphatase activity	3.1e-07	4	14.8	27	11	4566
hydrolase activity	6.4e-06	15	55.5	27	783	4566
protein modification	1.4e-05	9	33.3	27	271	4566
transition metal ion binding	2.7e-05	7	25.9	27	160	4566

Visual display

Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.

You can also view the images within GeneXPress by loading the module gxp file file.

>4x